ABSI CIK: 1672688

Absci Corp

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−75.2
FY22:
−107
FY23:
−116
FY24:
−109
FY25:
−120
(positive)
Change from FY21 to FY24
millions USD
FY21:
−99.8
FY22:
−91.3
FY23:
–
FY24:
−89.1
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−110
FY22:
−105
FY23:
−110
FY24:
−103
FY25:
−115
(positive)
Change from FY21 to FY25
millions USD
FY21:
−101
FY22:
−105
FY23:
−111
FY24:
−103
FY25:
−115

All amounts in millions USD Data sources:SEC EDGARTwelve Data